Cabinet for Economic Development
Kentucky High-Tech Small Businesses Receive SBIR-STTR Grants

Press Release Date:  Monday, November 16, 2009  
Contact Information:  Mandy Lambert, (502) 564-7670  

             Five Kentucky firms share $1.3 million from state to match federal awards


FRANKFORT, Ky. (November 16, 2009) – Governor Steve Beshear today announced five Kentucky high-tech companies will share over $1.3 million in state funds as part of a Kentucky initiative to attract and support technology-based small businesses by matching federal awards the companies have received.  The awards supplement over $24 million in federal funding made to the firms, including Louisville Bioscience, which established operations in Kentucky specifically because of the program. 

The state matching funds were awarded to businesses that received grants in Phase 1 or Phase 2 of the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Kentucky is the first and only state to match both phases of the federal program: up to $100,000 for Phase 1 federal awards and up to $500,000 per year (for up to two years) for Phase 2 federal awards.  

“To date, our unique SBIR-STTR program has made a total of 71 awards to 44 Kentucky companies for a combined $15.5 million, which has also helped bring eight new high-tech businesses to the Commonwealth,” said Gov. Beshear. “Kentucky is rapidly gaining national recognition for our support of technology-based companies, and this will have far-reaching effects as future innovators and entrepreneurs consider where to locate their businesses and high-tech jobs.” 

The five Kentucky companies receiving matching funds specialize in areas as diverse as human health and development, information technology, bioscience, and materials science and advanced manufacturing. 

The companies are: 

Adaptive Intelligent Systems, established in Lexington in 2005, is developing innovative, intelligent sensing and control technologies that help improve welding quality and productivity.  

SureGene, of Louisville, is developing and commercializing its AssureGene™ test, the first in a planned series of proprietary tests designed to help physicians provide more precise and individualized diagnoses for patients with bipolar disorder and schizophrenia.  

Vision Dynamics, located in Louisville, has developed an array of innovative materials, processes and equipment to manufacture advanced eyeglass lenses, including a nanotechnology-based system first marketed in 2006.  

Louisville Bioscience, of Louisville, is developing a blood test that profiles a patient’s blood plasma proteins to help detect autoimmune and infectious diseases, as well as cancer in the early stages. The new platform technology is also expected to have other applications, including identifying biomarkers and targets for new drugs. 

EndoProtech, located in Louisville, is developing and commercializing unique therapies for organ transplantation and cardiovascular surgery, including a product that will protect patients’ cells, tissues and organs that can be damaged when blood flow is restored following the procedures. 

The Cabinet for Economic Development, through its Department of Commercialization and Innovation, manages the Kentucky SBIR-STTR Matching Funds program, which is administered under contract by the Kentucky Science and Technology Corporation (KSTC).  

Applications for each round of the program are accepted by KSTC, which issues a solicitation approximately every 90 days. A link to the online guidelines and application form for the Kentucky program are posted at